← Back to Search

Device

Implantable Miniature Telescope (IMT) for Age-Related Macular Degeneration (TES Trial)

N/A

Waitlist Available

Led By Sumit Garg, MD

Research Sponsored by VisionCare, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up subjects will be followed up for three years post implantation

Awards & highlights

TES Trial Summary

This trial is a prospective, multicenter, single-arm study.

Eligible Conditions

Age-Related Macular Degeneration

TES Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ subjects will be followed up for three years post implantation

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~subjects will be followed up for three years post implantation

This trial's timeline: 3 weeks for screening, Varies for treatment, and subjects will be followed up for three years post implantation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adverse events

Secondary outcome measures

Decrease in best corrected distance visual acuity (BCDVA)

Endothelial Cell Density

Other outcome measures

Increase in best corrected distance visual acuity (BCDVA)

TES Trial Design

1Treatment groups

Experimental Treatment

Group I: Implantable Miniature Telescope (IMT)Experimental Treatment1 Intervention

Intervention: Implanting the Implantable Miniature Telescope (IMT) in pseudophakic eyes of patients suffering from binocular end-stage AMD.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

VisionCare, Inc.Lead Sponsor

9 Previous Clinical Trials

1,132 Total Patients Enrolled

Sumit Garg, MDPrincipal InvestigatorUniversity of California, Irvine

Derek Kunimoto, MDPrincipal InvestigatorRetinal Consultants of AZ

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many venues is this clinical experiment being overseen at?

"St. John's Clinic - Eye Specialists is one of fifteen global locations offering this trial, with additional sites located in Mercy (Springfield, Missouri), Loma Linda University Medical Center (Loma Linda, California) and the University of Michigan Kellogg Eye Centre (Ann Arbor, Michigan)."

Answered by AI

Are there any openings available for participants to join this experiment?

"Affirmative. According to the listings on clinicaltrials.gov, this trial is still in need of volunteers, having been originally posted on March 22nd 2017 and most recently edited a year later. It requires 75 participants between 14 separate clinical centres."

Answered by AI

What is the sample size for this investigation?

"To initiate the clinical trial, 75 participants must be admitted to the study and comply with predetermined requirements. Individuals can participate from St. John's Clinic - Eye Specialists, Mercy in Springfield Missouri, or Loma Linda University Medical Center in Loma Linda California."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Telescope Exchange Study

2017. "Telescope Exchange Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03011554.